The BTBR Mouse Model of Autism Spectrum Disorders Has Learning and Attentional Impairments and Alterations in Acetylcholine and Kynurenic Acid in Prefrontal Cortex

• Stephanie M. McTighe ,

  * E-mail: Stephanie.McTighe@pfizer.com (SMM); Daniel.Smith@autismspeaks.org (DGS)

  Affiliation Neuroscience Research Unit, Pfizer Global Research and Development, Cambridge, Massachusetts, United States of America

  ⨯
• Sarah J. Neal,

  Affiliation Neuroscience Research Unit, Pfizer Global Research and Development, Cambridge, Massachusetts, United States of America

  ⨯
• Qian Lin,

  Affiliation Neuroscience Research Unit, Pfizer Global Research and Development, Cambridge, Massachusetts, United States of America

  ⨯
• Zoë A. Hughes,

  Affiliation Neuroscience Research Unit, Pfizer Global Research and Development, Cambridge, Massachusetts, United States of America

  ⨯
• Daniel G. Smith

  * E-mail: Stephanie.McTighe@pfizer.com (SMM); Daniel.Smith@autismspeaks.org (DGS)

  Current address: Autism Speaks, Inc., Princeton, New Jersey, United States of America

  Affiliation Neuroscience Research Unit, Pfizer Global Research and Development, Cambridge, Massachusetts, United States of America

  ⨯